Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017		Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (982,219)		$ (487,389)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	14,403		13,826
Stock-based compensation	688,212		48,000
Change in warrant liability	(102,582)		0
Changes in operating assets and liabilities:
Inventory	(131,233)		(16,883)
Prepaid expenses	13,512		20,364
Accounts payable	79,830		(21,326)
Accrued expenses and accrued expenses – related parties	31,403		15,273
Net cash used in operating activities	(388,674)		(428,135)
Cash flows from investing activities:
Cost of registering patents	(5,930)		(6,269)
Net cash used in investing activities	(5,930)		(6,269)
Cash flows from financing activities:
Principal payments on notes payable and notes payable – related parties	(38,935)		(22,889)
Issuance of common stock for cash	60,000		0
Net cash provided by (used in) financing activities	21,065		(22,889)
Effects of foreign currency exchanges rates on cash	(2,177)		895
Net decrease in cash	(375,716)		(456,398)
Cash as of beginning of the period	398,290	[1]	745,078
Cash as of end of the period	22,574		288,680
Supplemental cash flow information:
Cash paid for interest	606		3,318
Supplemental disclosure of non-cash financing activities:
Financing of insurance premiums	$ 26,250		$ 31,500

[1] The condensed consolidated balance sheet as of December 31, 2016 has been prepared using information from the audited consolidated balance sheet as of that date.